MENU

KROS Keros Therapeutics Forecast, Technical & Fundamental Analysis

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs... Show more

KROS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
KROS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

KROS is expected to report earnings to fall 35.20% to -93 cents per share on November 11

Keros Therapeutics KROS Stock Earnings Reports
Q3'26
Est.
$-0.94
Q2'26
Missed
by $0.05
Q1'26
Missed
by $0.18
Q4'25
Missed
by $0.16
Q3'25
Beat
by $0.87
The last earnings report on August 03 showed earnings per share of -145 cents, missing the estimate of -139 cents. With 113.36K shares outstanding, the current market capitalization sits at 223.65M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology

Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
78
Web
https://www.kerostx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BBSC86.350.91
+1.07%
JPMorgan BetaBuilders U.S. Small Cap Equity Fund (BBSC)
LJAN24.700.01
+0.06%
Innovator Premium Income 15 Buffer ETF - January (LJAN)
SBND18.25N/A
N/A
Columbia Short Duration Bond ETF (SBND)
VGLT49.92-0.15
-0.30%
Vanguard Long-Term Treasury ETF (VGLT)
TWM23.57-0.40
-1.67%
ProShares UltraShort Russell2000 (TWM)

KROS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.89%
AXON - KROS
43%
Loosely correlated
-2.10%
ABEO - KROS
43%
Loosely correlated
+0.40%
EYPT - KROS
43%
Loosely correlated
+0.62%
IMVT - KROS
42%
Loosely correlated
-0.09%
SANA - KROS
40%
Loosely correlated
N/A
More
Keros Therapeutics (KROS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com